With a similar rationale as that of our current study, the utilization of radiomics for the detection of BRAF and CTNNB1 mutations in craniopharyngioma patients was successfully demonstrated by Chen et al., who achieved a level of accuracy of 0.93 in the detection of mutation status, and demonstrated the promising potential of radiomics for those mutations31. This evidence concerns the gene CTNNB1 and craniopharyngioma.